Trust Company of Vermont’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $9.1M | Sell |
8,466
-517
| -6% | -$494K | 0.38% | 66 |
|
|
2025
Q3 | $6.85M | Sell |
8,983
-32
| -0.4% | -$23.8K | 0.3% | 78 |
|
|
2025
Q2 | $7.03M | Buy |
9,015
+398
| +5% | +$309K | 0.33% | 72 |
|
|
2025
Q1 | $7.12M | Sell |
8,617
-42
| -0.5% | -$34.9K | 0.36% | 70 |
|
|
2024
Q4 | $6.68M | Buy |
8,659
+542
| +7% | +$449K | 0.32% | 76 |
|
|
2024
Q3 | $7.19M | Sell |
8,117
-171
| -2% | -$154K | 0.36% | 72 |
|
|
2024
Q2 | $7.5M | Buy |
8,288
+131
| +2% | +$105K | 0.41% | 66 |
|
|
2024
Q1 | $6.35M | Buy |
8,157
+1,222
| +18% | +$870K | 0.35% | 74 |
|
|
2023
Q4 | $4.04M | Sell |
6,935
-469
| -6% | -$274K | 0.27% | 91 |
|
|
2023
Q3 | $3.98M | Buy |
7,404
+57
| +0.8% | +$29.4K | 0.27% | 95 |
|
|
2023
Q2 | $3.45M | Sell |
7,347
-42
| -0.6% | -$17.6K | 0.22% | 106 |
|
|
2023
Q1 | $2.54M | Sell |
7,389
-93
| -1% | -$31.4K | 0.18% | 124 |
|
|
2022
Q4 | $2.74M | Buy |
7,482
+293
| +4% | +$104K | 0.2% | 112 |
|
|
2022
Q3 | $2.33M | Sell |
7,189
-318
| -4% | -$101K | 0.18% | 118 |
|
|
2022
Q2 | $2.43M | Sell |
7,507
-145
| -2% | -$43.5K | 0.19% | 116 |
|
|
2022
Q1 | $2.19M | Sell |
7,652
-92
| -1% | -$23.7K | 0.15% | 129 |
|
|
2021
Q4 | $2.14M | Buy |
7,744
+308
| +4% | +$78.1K | 0.13% | 134 |
|
|
2021
Q3 | $1.72M | Sell |
7,436
-147
| -2% | -$36.3K | 0.12% | 140 |
|
|
2021
Q2 | $1.74M | Buy |
7,583
+17
| +0.2% | +$3.42K | 0.12% | 141 |
|
|
2021
Q1 | $1.41M | Sell |
7,566
-945
| -11% | -$185K | 0.11% | 151 |
|
|
2020
Q4 | $1.44M | Hold |
8,511
| – | – | 0.11% | 138 |
|
|
2020
Q3 | $1.26M | Sell |
8,511
-115
| -1% | -$17.8K | 0.12% | 141 |
|
|
2020
Q2 | $1.42M | Sell |
8,626
-521
| -6% | -$80K | 0.14% | 127 |
|
|
2020
Q1 | $1.27M | Sell |
9,147
-29
| -0.3% | -$3.98K | 0.12% | 139 |
|
|
2019
Q4 | $1.21M | Buy |
9,176
+33
| +0.4% | +$3.83K | 0.09% | 157 |
|
|
2019
Q3 | $1.02M | Sell |
9,143
-138
| -1% | -$15.4K | 0.08% | 166 |
|
|
2019
Q2 | $1.03M | Sell |
9,281
-56
| -0.6% | -$6.59K | 0.09% | 164 |
|
|
2019
Q1 | $1.21M | Sell |
9,337
-199
| -2% | -$24.2K | 0.1% | 155 |
|
|
2018
Q4 | $1.1M | Sell |
9,536
-93
| -1% | -$10.4K | 0.11% | 154 |
|
|
2018
Q3 | $1.03M | Sell |
9,629
-79
| -0.8% | -$7.9K | 0.09% | 168 |
|
|
2018
Q2 | $828K | Buy |
9,708
+893
| +10% | +$73.3K | 0.07% | 182 |
|
|
2018
Q1 | $682K | Sell |
8,815
-196
| -2% | -$15.8K | 0.06% | 193 |
|
|
2017
Q4 | $761K | Sell |
9,011
-55
| -0.6% | -$4.68K | 0.07% | 189 |
|
|
2017
Q3 | $775K | Sell |
9,066
-100
| -1% | -$8.2K | 0.08% | 183 |
|
|
2017
Q2 | $754K | Sell |
9,166
-1,270
| -12% | -$104K | 0.08% | 186 |
|
|
2017
Q1 | $878K | Sell |
10,436
-612
| -6% | -$49K | 0.09% | 164 |
|
|
2016
Q4 | $813K | Buy |
11,048
+360
| +3% | +$26.8K | 0.09% | 168 |
|
|
2016
Q3 | $858K | Buy |
10,688
+400
| +4% | +$32K | 0.11% | 152 |
|
|
2016
Q2 | $810K | Hold |
10,288
| – | – | 0.11% | 152 |
|
|
2016
Q1 | $741K | Buy |
10,288
+201
| +2% | +$15.2K | 0.1% | 152 |
|
|
2015
Q4 | $850K | Sell |
10,087
-422
| -4% | -$35K | 0.12% | 148 |
|
|
2015
Q3 | $879K | Buy |
10,509
+100
| +1% | +$8.44K | 0.14% | 145 |
|
|
2015
Q2 | $869K | Hold |
10,409
| – | – | 0.13% | 152 |
|
|
2015
Q1 | $756K | Sell |
10,409
-50
| -0.5% | -$3.56K | 0.11% | 154 |
|
|
2014
Q4 | $721K | Sell |
10,459
-100
| -0.9% | -$6.75K | 0.11% | 159 |
|
|
2014
Q3 | $685K | Buy |
10,559
+435
| +4% | +$27.5K | 0.1% | 157 |
|
|
2014
Q2 | $630K | Hold |
10,124
| – | – | 0.1% | 156 |
|
|
2014
Q1 | $596K | Buy |
10,124
+200
| +2% | +$11.2K | 0.1% | 158 |
|
|
2013
Q4 | $506K | Sell |
9,924
-470
| -5% | -$23.5K | 0.08% | 165 |
|
|
2013
Q3 | $523K | Buy |
10,394
+70
| +0.7% | +$3.67K | 0.1% | 155 |
|
|
2013
Q2 | $507K | Buy |
+10,324
| New | +$562K | 0.1% | 150 |
|
Other funds holding LLY
Trust Company of Vermont's LLY Position: Q4 2025 in Review
Trust Company of Vermont reduced its Eli Lilly (LLY) stake by 5.8% in Q4 2025, selling an estimated $494K and leaving 8,466 shares worth $9.1M. The position accounts for 0.38% of the portfolio, ranked #66.
Trust Company of Vermont first reported a position in LLY in Q2 2013 and has held it in 51 quarters since. 4,430 funds tracked by Wall St. Rank hold LLY as of Q4 2025.
- Trust Company of Vermont held 8,466 shares of Eli Lilly worth $9.1M as of Q4 2025.
- Trust Company of Vermont sold 517 Eli Lilly shares in Q4 2025, an estimated $494K.
- Eli Lilly made up 0.38% of Trust Company of Vermont's portfolio in Q4 2025, its #66 holding.
- Trust Company of Vermont first reported a position in Eli Lilly in Q2 2013 and has held it in 51 quarters since.
- 4,430 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.
Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.